Trial Comparing the Safety of Two Different Intravenous Iron Formulations
NCT ID: NCT00593619
Last Updated: 2009-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE4
200 participants
INTERVENTIONAL
2008-01-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin
NCT00239616
Comparison Between Effects of Two Iron Preparations on Protein in the Urine
NCT00534144
Effect of Two Iron Preparations on Protein in the Urine
NCT00354692
Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients
NCT06556134
A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia
NCT01114204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iron Dextran
Iron dextran
300mg in 250cc normal saline given over 2 hours
Iron Sucrose
Iron sucrose
300mg in 250cc normal saline given over 2 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iron dextran
300mg in 250cc normal saline given over 2 hours
Iron sucrose
300mg in 250cc normal saline given over 2 hours
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To be receiving intravenous iron
Exclusion Criteria
* Hemodialysis
* Previous exposure to intravenous iron
* Unable to provide written consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
London Health Sciences Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
London Health Sciences Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ian H Chin-Yee, MD, FRCPC
Role: PRINCIPAL_INVESTIGATOR
London Health Sciences Centre
Fiona E Ralley, MB ChB, FRCA
Role: PRINCIPAL_INVESTIGATOR
London Health Sciences Centre
Cyrus C Hsia, MD,FRCPC
Role: STUDY_DIRECTOR
London Health Sciences Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
London Health Sciences Centre
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSREB13767
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.